
Aethlon Medical AEMD
$ 2.27
-2.16%
Quarterly report 2025-Q4
added 02-12-2026
Aethlon Medical Gross Profit 2011-2026 | AEMD
Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.
Calculation formula:Importance for business:
Gross Profit = Revenue – Cost of Goods Sold (COGS)
Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
- Raw materials and supplies
- Wages of production personnel
- Depreciation of equipment
- Transportation and warehousing costs (if directly related to production)
- Assessing core business profitability
If gross profit is declining, it may indicate rising production costs or falling sales. - Financial planning
Gross profit is the basis for calculating other key metrics, such as operating and net profit. - Benchmarking against competitors
Gross profit analysis helps compare the efficiency of different companies within the same industry. - Insights into pricing effectiveness
If gross profit is low, the company may be pricing too low or failing to control costs effectively.
- Increase in raw material and supply costs
- Rising production expenses
- Price reductions due to competition
- Decrease in sales volume
- Currency exchange rate fluctuations (for imports/exports)
Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.
Annual Gross Profit Aethlon Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | 1.36 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.36 M | 1.36 M | 1.36 M |
Gross Profit of other stocks in the Medical devices industry
| Issuer | Gross Profit | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
BioSig Technologies
BSGM
|
229 K | - | 37.08 % | $ 85.7 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
67.9 M | - | - | $ 1.77 B | ||
|
Delcath Systems
DCTH
|
73.4 M | $ 9.13 | -0.76 % | $ 327 M | ||
|
Axonics Modulation Technologies
AXNX
|
198 M | - | - | $ 3.31 B | ||
|
Dynatronics Corporation
DYNT
|
6.01 M | - | 14.99 % | $ 929 K | ||
|
Aziyo Biologics
AZYO
|
6.6 M | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
-3.14 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
443 K | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
584 K | - | -5.86 % | $ 30.6 M | ||
|
Conformis
CFMS
|
23.2 M | - | - | $ 16.4 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
953 M | $ 9.38 | -1.78 % | $ 722 M | ||
|
Cardiovascular Systems
CSII
|
173 M | - | 0.15 % | $ 844 M | ||
|
Second Sight Medical Products
EYES
|
500 K | - | -0.97 % | $ 54.4 M | ||
|
Apollo Endosurgery
APEN
|
42.4 M | - | - | $ 475 M | ||
|
Inogen
INGN
|
154 M | $ 6.5 | 1.25 % | $ 173 M | ||
|
IRIDEX Corporation
IRIX
|
21.8 M | $ 1.35 | 1.89 % | $ 21.8 M | ||
|
IRadimed Corporation
IRMD
|
64.3 M | $ 98.74 | -2.99 % | $ 1.26 B | ||
|
OrthoPediatrics Corp.
KIDS
|
173 M | $ 16.35 | 0.74 % | $ 384 M | ||
|
Avinger
AVGR
|
2 M | - | -20.74 % | $ 369 K | ||
|
CryoLife, Inc.
CRY
|
168 M | - | -4.14 % | $ 702 M | ||
|
LENSAR
LNSR
|
14.1 M | $ 5.52 | -1.08 % | $ 63.6 M | ||
|
CONMED Corporation
CNMD
|
750 M | $ 36.64 | -1.19 % | $ 1.14 B | ||
|
Medtronic PLC
MDT
|
19.6 B | $ 87.67 | -0.24 % | $ 113 B | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
4.25 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
28.7 M | - | 0.03 % | $ 1.58 B | ||
|
NanoVibronix
NAOV
|
1.51 M | - | - | $ 1.08 M | ||
|
Electromed
ELMD
|
50 M | $ 24.45 | -0.85 % | $ 207 M | ||
|
Misonix, Inc.
MSON
|
43.7 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
1.99 M | - | - | $ 111 M | ||
|
Orthofix Medical
OFIX
|
566 M | $ 11.79 | -1.17 % | $ 467 M | ||
|
Outset Medical
OM
|
46.8 M | $ 3.52 | -0.28 % | $ 53.5 K | ||
|
Intersect ENT, Inc.
XENT
|
50.2 M | - | - | $ 955 M | ||
|
Cytosorbents Corporation
CTSO
|
25.1 M | $ 0.6 | -10.61 % | $ 32.7 M | ||
|
PAVmed
PAVM
|
-85 K | $ 8.94 | -3.87 % | $ 64.7 M | ||
|
BIOLASE
BIOL
|
16.7 M | - | -13.19 % | $ 166 K | ||
|
LivaNova PLC
LIVN
|
940 M | $ 63.65 | 0.55 % | $ 3.47 B | ||
|
InspireMD
NSPR
|
2.65 M | $ 1.73 | -2.26 % | $ 111 M | ||
|
Insulet Corporation
PODD
|
1.94 B | $ 218.11 | 0.98 % | $ 15.3 B | ||
|
AdaptHealth Corp.
AHCO
|
89.3 M | $ 11.41 | 0.18 % | $ 1.54 B | ||
|
Quanterix Corporation
QTRX
|
65 M | $ 3.9 | -1.52 % | $ 166 M | ||
|
Penumbra
PEN
|
942 M | $ 336.42 | 0.04 % | $ 13.1 B | ||
|
MiMedx Group
MDXG
|
346 M | $ 3.94 | -3.9 % | $ 582 M | ||
|
Invacare Corporation
IVC
|
48.3 M | - | - | $ 24.7 M | ||
|
Ra Medical Systems
RMED
|
-147 K | - | 10.0 % | $ 610 K | ||
|
Myomo
MYO
|
26.9 M | $ 0.68 | -2.2 % | $ 28.5 M | ||
|
Inspire Medical Systems
INSP
|
779 M | $ 50.45 | -1.87 % | $ 1.48 B |